Diseases [C] » Digestive System Diseases [C06] » Biliary Tract Diseases » Bile Duct Diseases » Cholestasis
Description
Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). MeSH
Hierarchy View
Subtype Terms (3)
Cholestasis, Extrahepatic
1 approved drug
Cholestasis, Intrahepatic
11 drugs (8 approved, 3 experimental)
Approved Indicated Drugs (4)
Phase 4 Indicated Drugs (3)
Phase 2 Indicated Drugs (3)
Other Experimental Indicated Drugs (6)
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (50)
ASPEN Rhoads Research Foundation
Assistance Publique - Hôpitaux de Paris
Beijing Trendful Kangjian Medical Information Consulting Limited Company
Epsom and St Helier University Hospitals NHS Trust
Huazhong University of Science and Technology
Kapiolani Medical Center For Women & Children
Mednax Center for Research, Education and Quality
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NO.6 People's Hospital of Hangzhou
Organization Involved with Phase 2 Indications (19)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (13)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.